Purchase Order 75A50121P00026
Award Date 2/3/21
Potential Completion Date 2/2/22
Potential Value $5.7M
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Boulder, CO 80303, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, is for the development and delivery of a high-performance point-of-care antibody test to assess immunity to the SARS-CoV-2 virus and confirm positive antibody tests. The $275,000 Firm Fixed Price contract was awarded on June 17, 2020 by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services. This contract was not set aside...
- The U.S. Air Force awarded a $35,089,000 firm-fixed-price contract to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, to scale up manufacturing capacity for ultra-rapid point-of-care COVID-19 tests. The contract, which has a completion date of March 31, 2023, does not have a set-aside designation. Mbio Diagnostics is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck platform technology. Through past prime...
- This is a $2,761,705.00 Firm Fixed Price Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics. The contract is for the development of point-of-care monitoring of the host-pathogen interaction during infection. Mbio Diagnostics Inc. is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order contract to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the "Rapid Detection of Legionella in Environmental Samples with Speciation and Serotyping." The contract, valued at $149,900.00, was set aside for a small business. Mbio Diagnostics Inc. is a company that develops diagnostic tests and devices, including rapid point-of-care tests,...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a firm fixed-price purchase order contract worth $5,389,813.00 to Luminex Corporation. The contract is for the integration of the SARS-CoV-2 virus with the NxTAG Respiratory Pathogen Panel and the submission of a 510(k) application to the U.S. Food and Drug Administration. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
- Luminex Corporation was awarded a $642,450 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an extended panel for the Luminex NXTAG COVID-19 diagnostic test. The contract is being performed in Austin, Texas over a period of four months ending July 1, 2020. This award was made under Special Instructions 019 of the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which...
- Minute Molecular Diagnostics, Inc. was awarded a definitive, firm fixed price contract valued at seventeen million, five hundred ninety thousand dollars by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for the RADX TECH PROJECT 2200 to develop a high-throughput, fast-turnaround, field-deployable COVID-19 molecular diagnostic system. Work will be performed in Evanston, Illinois with a period of performance...
- This is a $24,860,014.00 firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Mesa Biotech Inc. for the development of an easy-to-use, low-cost molecular-based SARS-CoV-2 test. The contract is part of the Rapid Acceleration of Diagnostics (RADx) program, which aims to accelerate the development, validation, and commercialization of innovative COVID-19 testing technologies. The contract has a performance period ending on May 4, 2024,...
- This is a $2,400,000.00 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS), Administration for Strategic Preparedness and Response (ASPR), Center for Industrial Base Expansion and Supply Chain (IBMSC) to Watmind USA, Inc., a small disadvantaged business. The contract is to provide 1,000,000 commercial off-the-shelf multi-antigen diagnostic test kits capable of detecting SARS-CoV-2 and Influenza A/B. The objective is to ensure the government is...